Showing results (231-240 of 999) with videos related to

Sort By:
Pageof 100
Ejhaem|July 3, 2026
MRI Predictors of Outcome in Primary Central Nervous System Lymphoma Patients Before and After Autologous Stem Cell TransplantDewen Meng, Hamza Alshuft, Christopher P Fox, et al.
Ejhaem|July 6, 2026
Targeting CD162 for Life-Threatening Cutaneous Chronic Graft-Versus-Host Disease: A Case ReportAlicia Lieberman, Ross McCauley, Maureen Ross, et al.
Ejhaem|July 3, 2026
Sinusoidal Obstruction Syndrome With Inotuzumab Ozogamicin Combined With Ponatinib for Philadelphia-Chromosome-Positive Lymphoblastic MalignanciesEmi Yokoyama, Satoshi Ota, Yasuo Sakurai, et al.
Ejhaem|July 8, 2026
Immune Effector Cell-Associated Hematotoxicity With Secondary Myelofibrosis Following Idecabtagene-Vicleucel for Multiple Myeloma, Comprehensively Treated With Autologous Hematopoietic Stem Cell BoostingKeishi Ogura, Takahiro Fujino, Takahisa Nakamura, et al.
Ejhaem|July 9, 2026
Polatuzumab Vedotin Enhances Intratumoral T-Cell Infiltration and Demonstrates Combinatorial Efficacy With Anti-CD20/CD3 Bispecific Antibody in a Syngeneic B-Cell Malignancy Mouse ModelMayu Tomita, Sei Shu, Natsumi Kawasaki, et al.
Ejhaem|July 8, 2026
Effectiveness and Safety of Prophylactic Low-Dose Emicizumab in Young Children With Hemophilia A: A Multicenter Retrospective StudyGuichi Zhou, Liya He, Chunyan Wang, et al.
Ejhaem|April 17, 2026
Concurrent SF3B1 Mutation and BCR::ABL1 Demonstrating a Myelodysplastic Syndrome Phenotype: A Case ReportEugene Brailovski, Amirali Vahedi, Véronique Lisi, et al.
Ejhaem|April 16, 2026
Adding Bortezomib and Bendamustine to High-Dose Melphalan in Autologous Haematopoietic Stem Cell Transplantation for Relapsed Multiple Myeloma-A Single Centre Retrospective StudyThomas Silfverberg, Honar Cherif, Emma Smitt, et al.
Ejhaem|April 15, 2026
Reciprocal Clonal Dynamics of Independent FLT3 D835V-Positive Acute Myeloid Leukemia and Chronic Myeloid Leukemia With GilteritinibKai Osone, Seiichiro Katagiri, SungGi Chi, et al.
Ejhaem|August 14, 2026
A Real-World Study Characterizing a US Population of Patients Receiving Rituximab With Gemcitabine and Oxaliplatin for Relapsed or Refractory Large B-Cell LymphomaL Elizabeth Budde, Adam J Olszewski, Bei Hu, et al.
Pageof 100